MARATTO

article · Ain Shams Medical Journal

Employing LI-RADS on dynamic MRI scans for distinguishing hepatocellular carcinoma from other hepatic focal lesions in high risk patients

2024Open accessMenoufia University

Abstract

ABackground: LI-RADS (Liver Imaging Reporting and Data System) provide standardization for screening high risk patients for hepatocellular carcinoma (HCC). Moreover, it aids in treatment response assessment. HCC is special among different malignancies in having tumor hallmark on dynamic CT or MRI that permit accurate diagnosis without an invasive biopsy. Objective: To appraise LI-RADS on dynamic MRI scans for distinguishing hepatocellular carcinoma from other hepatic focal lesions in high risk patients.Patients and methods: This study was designed in a retrospective pattern. It included eighty five high risk patients for hepatocellular carcinoma who had undergone dynamic MRI scans. Dynamic MRI scans were evaluated using LI-RADS features for distinguishing hepatocellular carcinoma from other hepatic focal lesions. Eventually, the obtained results were correlated with serial imaging follow-up or histopathological diagnosis as the diagnostic standard of reference.Results: The majority of the included patients were found to have malignant lesions (67.1%) predominantly HCC (45.9%), followed by cholangiocarcinoma (8.2%) and finally hepatic deposits (7.1%). Considering LI-RADS categorization, hemangioma was most common among LIRAD1 group (60%), regeneration nodule among LIRAD 2 group (88.9%), dysplastic nodule among both LIRAD3 (50%) and LIRAD 4 groups (55.6). HCC among LIRAD5 group (100%). Finally, cholangiocarcinoma among LRM group (53.8 %).Conclusions: Employing LI-RADS on dynamic MRI scans for distinguishing hepatocellular carcinoma from other hepatic focal lesions in high risk patients improves patient management Keywords: Hepatic focal lesions, HCC, LI-RADS, Magnetic resonance imaging, Benign, Malignant

Research topics

  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/asmj.2023.208805.1120

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.